NORAD and neuroblastoma: Having established the baseline effect of knocking down NORAD, the authors attempted to establish the effect of NORAD knockdown on the chemoresistance of NB cell lines, inclusive of SK-N-SH and IMR-32 treated with Doxorubicin (DOX) [33].